Skip to content

Clinical trials

Terminated Glioblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Status: Terminated Country / region: United States Clear all

204 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20032
20042
20055
20066
20077
200810
20097
201013
201113
201211
201311
201411
20158
201613
201715
201813
201911
202012
20217
20229
20237
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated204

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)19
M.D. Anderson Cancer Center11
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins10
Wake Forest University Health Sciences6
Pediatric Brain Tumor Consortium4
AbbVie3
Case Comprehensive Cancer Center3
Northwestern University3
Novartis Pharmaceuticals3
Tocagen Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma204
Brain Neoplasms71
Glioma67
Gliosarcoma63
Astrocytoma60
Oligodendroglioma41
Central Nervous System Neoplasms19
Ependymoma16
Neoplasms10
Recurrence8

Trials

Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.

104 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.